RCM Technologies, Inc. (RCMT) closed the most recent trading day at $27.01, moving +1.81% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.59%. Meanwhile, the Dow ...

In ambulatory care, financial health is inextricably linked to operational efficiency. Revenue cycle management (RCM) is the backbone of practice sustainability, yet it is fraught with complexities, ...

Consumer sentiment weakened in September as the RealClearMarkets/TIPP Economic Optimism Index, the first read on U.S. consumer confidence each month, fell from 50.9 in August to 48.7, a 2.2-point ...

RCM Technologies has reversed its earnings decline, delivering strong Q4 2024 and Q1 2025 results, and I continue to rate it a buy. The company’s focus on growth over profitability is paying off, with ...

Hospitals are finding it harder than ever to collect payment for the care they provide, which is one of the many factors causing widespread financial strain among the nation’s providers. Many ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--i3 Verticals, Inc. (“i3 Verticals” or the “Company”) (NASDAQ: IIIV), and Infinx, Inc. (“Infinx”), a leader in AI ...

Good morning, and thank you for joining us. This is Kevin Miller, Chief Financial Officer of RCM Technologies. I am joined today by Brad Vizi, RCM's Executive Chairman. Our presentation and this call ...

Healthcare technology company athenahealth, introduced new automation and AI-based software innovations that streamlines and lowers the burden of revenue cycle management (RCM) for thousands of ...

The Revenue Cycle Management Technology Adoption Model (RCMTAM) is a peer-reviewed, five-stage framework from the Healthcare Financial Management Association and FinThrive that assesses operational ...

Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice have completed their $8.9 billion acquisition of R1 RCM. With the completion of the transaction, R1’s common stock has ...

R1 RCM Inc. (RCM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to break-even earnings per share a year ago. These figures are ...